145 related articles for article (PubMed ID: 4373634)
21. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
Goldstein DS
J Appl Physiol (1985); 2010 Dec; 109(6):2005-6. PubMed ID: 21188816
[No Abstract] [Full Text] [Related]
22. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Carotid stimulation studies support a prominent role for the sympathetic nervous system.
Wehrwein EA
J Appl Physiol (1985); 2010 Dec; 109(6):2009. PubMed ID: 21188821
[No Abstract] [Full Text] [Related]
23. What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes?
Barrett CJ; Ramchandra R; Guild SJ; Lala A; Budgett DM; Malpas SC
Circ Res; 2003 Jun; 92(12):1330-6. PubMed ID: 12764023
[TBL] [Abstract][Full Text] [Related]
24. [Interaction between neurogenic and renal factors of pathogenesis of hypertension].
Markov KhM
Kardiologiia; 1970 Feb; 10(2):144-57. PubMed ID: 4316917
[No Abstract] [Full Text] [Related]
25. Increased cardiovascular reactivity in renal infarction hypertension.
Basso N; de la Riva IJ
Acta Physiol Lat Am; 1974; 24(2):109-18. PubMed ID: 4375405
[No Abstract] [Full Text] [Related]
26. [Reflex control of the renal secretion of renin].
Mancia G; Romero JC; Shepherd JT
Boll Soc Ital Cardiol; 1975; 20(10):1155-8. PubMed ID: 1234415
[No Abstract] [Full Text] [Related]
27. [Some aspects of the physiopathology of arterial hypertension].
Francischetti EA; Oigman W; Fagundes VG; Netto FR; Sanjuliani AF; Brandão AP
Arq Bras Cardiol; 1984 Feb; 42(2):153-65. PubMed ID: 6089717
[No Abstract] [Full Text] [Related]
28. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
Li P
J Appl Physiol (1985); 2010 Dec; 109(6):2008. PubMed ID: 21188819
[No Abstract] [Full Text] [Related]
29. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Ruzicka M; Coletta E; Leenen FH
Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
[TBL] [Abstract][Full Text] [Related]
30. Actions of angiotensin on the central nervous system.
Buckley JP
Fed Proc; 1972; 31(4):1332-7. PubMed ID: 4402612
[No Abstract] [Full Text] [Related]
31. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--involvement of the CNS to this complex puzzle.
Moreira TS; Takakura AC; Antunes VR
J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188814
[No Abstract] [Full Text] [Related]
32. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
33. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
Matsukawa T; Mano T; Gotoh E; Ishii M
J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
35. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
Head GA; Burke SL
J Appl Physiol (1985); 2010 Dec; 109(6):2010. PubMed ID: 21188825
[No Abstract] [Full Text] [Related]
36. Oral contraceptive-induced high blood pressure is prevented by renin-angiotensin suppression in female rats but not by sympathetic nervous system blockade.
Olatunji LA; Soladoye AO
Indian J Exp Biol; 2008 Nov; 46(11):749-54. PubMed ID: 19090344
[TBL] [Abstract][Full Text] [Related]
37. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Hung jury?
Bie P; Damkjaer M
J Appl Physiol (1985); 2010 Dec; 109(6):2011. PubMed ID: 21188841
[No Abstract] [Full Text] [Related]
38. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
Chikhladze NM
Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
[No Abstract] [Full Text] [Related]
39. [Mechanisms of the pressure effect of synthetic angiotensin-2 on arterial pressure].
Riazhenov VV; Kudrin AN; Babkina TA
Farmakol Toksikol; 1973; 36(1):36-9. PubMed ID: 4405496
[No Abstract] [Full Text] [Related]
40. The sympathetic nervous system in primary hypertension.
Weber MA; Drayer JI
Miner Electrolyte Metab; 1982 Feb; 7(2):57-66. PubMed ID: 6763142
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
